Skip to Main Content

Author Details

Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
2004
155
26
PMIDPaper TitleJournal TitlePublished Year
37696743Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer.Eur Urol Focus2024
36283936Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.Eur Urol Oncol2023
37491942Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network.Arch Ital Urol Androl2023
37587925A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device.Clin Transl Radiat Oncol2023
37792435An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study.JMIR Cancer2023
37730609Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.Radiat Oncol2023
37682613Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies.Clin Nucl Med2023
37461140Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis.BJU Int2023
37187202Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Lancet Oncol2023
37285311The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer.J Natl Cancer Inst2023
37117112Physician Perception of Grade Group 1 Prostate Cancer.Eur Urol Focus2023
37284049Oligometastasis in Prostate Cancer: Can We Learn from Those "Excluded" from a Phase 2 Trial?Eur Urol Open Sci2023
37103562Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.Urol Pract2023
37270247Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making.Int J Radiat Oncol Biol Phys2023
37137444Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.Int J Radiat Oncol Biol Phys2023
37099737Reply to X. Farré et al.JCO Glob Oncol2023
37433574Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer.BJU Int2023
37268513Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease.Eur Urol Focus2023
37165117Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery.J Neurooncol2023
37032280Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?Eur Urol Focus2023
37265510Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.Tech Innov Patient Support Radiat Oncol2023
36549968Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.Brachytherapy2023
36809425The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.Eur J Nucl Med Mol Imaging2023
36737311Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy.Clin Oncol (R Coll Radiol)2023
36459669Reply to M. Baboudjian et al.J Clin Oncol2023
36414526Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trial.Brachytherapy2023
36821811Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience.JCO Oncol Pract2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
32605887Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.Eur Urol Oncol2022
35474015Factors correlating with survival following adjuvant or definitive radiosurgery for large brain metastases.Neuro Oncol2022
35608445Impact of <sup>18</sup>F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.Radiology2022
35436144Low-Grade Prostate Cancer: Time to Stop Calling It Cancer.J Clin Oncol2022
35534628Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
35393232The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.Urol Oncol2022
35562268TNM Staging of Prostate Cancer: Challenges in Securing a Globally Applicable Classification.Eur Urol2022
35622151Correction to: Exploring the value of using patientâ¿¿oriented MRI reports in clinical practice - a pilot study.Support Care Cancer2022
36465337Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.Front Oncol2022
36421354COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices.Curr Oncol2022
36001857Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.J Clin Oncol2022
36244387Stereotactic Body Radiation Therapy for Oligometastasis: GUst Do It?Int J Radiat Oncol Biol Phys2022
36105770Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.Tech Innov Patient Support Radiat Oncol2022
36331536Virtual Care and Electronic Patient Communication During COVID-19: Cross-sectional Study of Inequities Across a Canadian Tertiary Cancer Center.J Med Internet Res2022
36031465Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.Int J Radiat Oncol Biol Phys2022
36091157MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.Front Oncol2022
34919885FACE Value of Patient-Reported Outcomes in Dose-Escalated Radiation Therapy for Prostate Cancer.Int J Radiat Oncol Biol Phys2022
35252598Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy.Tech Innov Patient Support Radiat Oncol2022
35200575The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review.Curr Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34672938Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring.Can Urol Assoc J2022
34705287COVID-19 and patients with cancer: Investigating treatment impact, information sources, and COVID-19-related knowledge, attitudes, and practices.Cancer2022
  • 1 - 50 of 155

Recommended Authors

Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 23
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 28
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 30
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 33
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 37
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 6
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 9
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 26
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 16
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 14
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 48
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 26
Mitchell Kamrava
Cedars Sinai Medical Center
Career Start Year 2005
Number of shared co-authors 17
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 28
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 59
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 4
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 14
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 17
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 37
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 19
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 30
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 29
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 30
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 24
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 26
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 42
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 35
Fred Saad
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 69
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 49
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 71

Collaborators

Neil E Fleshner
University of Toronto
Co-authored papers 38
Robert G Bristow
University of Toronto
Co-authored papers 25
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 22
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 17
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 17
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 17
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 16
Paul C Boutros
University of California los angeles
Co-authored papers 16
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 12
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 12
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 11
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 10
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 10
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers 9
Gelareh Zadeh
University of Toronto
Co-authored papers 9
Robert T Dess
University of Michigan ann arbor
Co-authored papers 9
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
Bradley J Stish
Mayo Clinic
Co-authored papers 8
Katherine Lajkosz
Princess Margaret Hospital
Co-authored papers 8
Jure Murgic
University Hospital Center Sestre Milosrdnice
Co-authored papers 7
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 7
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 7
Thomas M Pisansky
Mayo Clinic
Co-authored papers 7
Amar U Kishan
University of California los angeles
Co-authored papers 7
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 6
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 6
Elai Davicioni
Veracyte Inc.
Co-authored papers 6
Brian J Davis
Mayo Clinic
Co-authored papers 6
Ali Hosni
Princess Margaret Cancer Center
Co-authored papers 6
Curtiland Deville
Johns Hopkins University
Co-authored papers 6
Release 1.2